Literature DB >> 18634828

Increased sensitivity for detecting avian influenza-specific antibodies by a modified hemagglutination inhibition assay using horse erythrocytes.

Na Jia1, Shi-Xia Wang, Yun-Xi Liu, Pan-He Zhang, Shu-Qing Zuo, Rong-Li Dang, Yong-Hong Ma, Chunhua Zhang, Lu Zhang, Shan Lu, Wu-Chun Cao.   

Abstract

The hemagglutination inhibition (HI) assay is a widely used serological method to measure the levels of protective antibody responses against influenza viruses. However, the traditional HI assay which uses chicken erythrocytes is not sufficiently sensitive for detecting HI antibodies specific to avian influenza viruses. Previously, it was demonstrated that employing an assay using horse erythrocytes was able to increase the sensitivity of HI assay. The current report describes further optimization of this modified HI assay. It was shown that this method was able to increase detection of HI activities in rabbit sera immunized with H5 HA antigens, and proved that this increased sensitivity is useful in dissecting the strain specificity of HI antibody responses. In addition, the modified HI assay using horse erythrocytes increased the sensitivity of detecting HI antibodies specific for three major serotypes of avian influenza viruses, H5, H7 and H9, in people who may have asymptomatic infection with avian influenza viruses. Based on these results, the optimized use of horse erythrocytes should be standard practice for detecting HI activities against avian influenza viruses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18634828     DOI: 10.1016/j.jviromet.2008.06.016

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  15 in total

1.  Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads.

Authors:  Dace V Madore; Bruce D Meade; Fran Rubin; Carolyn Deal; Freyja Lynn
Journal:  Vaccine       Date:  2010-05-12       Impact factor: 3.641

2.  Compatibility of H9N2 avian influenza surface genes and 2009 pandemic H1N1 internal genes for transmission in the ferret model.

Authors:  J Brian Kimble; Erin Sorrell; Hongxia Shao; Philip L Martin; Daniel Roberto Perez
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

3.  A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia.

Authors:  Ryuta Uraki; Zhenyu Piao; Yukihiro Akeda; Kiyoko Iwatsuki-Horimoto; Maki Kiso; Makoto Ozawa; Kazunori Oishi; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2015-06-29       Impact factor: 5.226

4.  Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus.

Authors:  Erin M Sorrell; Hongquan Wan; Yonas Araya; Haichen Song; Daniel R Perez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-20       Impact factor: 11.205

5.  Impact of erythrocyte species on assays for influenza serology.

Authors:  C M Trombetta; C Ulivieri; R J Cox; E J Remarque; C Centi; D Perini; G Piccini; S Rossi; S Marchi; E Montomoli
Journal:  J Prev Med Hyg       Date:  2018-03-30

Review 6.  Immunological assessment of influenza vaccines and immune correlates of protection.

Authors:  Adrian Reber; Jacqueline Katz
Journal:  Expert Rev Vaccines       Date:  2013-05       Impact factor: 5.217

7.  Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humans.

Authors:  Robert B Couch; William K Decker; Budi Utama; Robert L Atmar; Diane Niño; Jing Qi Feng; Matthew M Halpert; Gillian M Air
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

8.  Impact of antigenic and genetic drift on the serologic surveillance of H5N2 avian influenza viruses.

Authors:  Magdalena Escorcia; Karol Carrillo-Sánchez; Santiago March-Mifsut; Joaquin Chapa; Eduardo Lucio; Gerardo M Nava
Journal:  BMC Vet Res       Date:  2010-12-20       Impact factor: 2.741

9.  Polyvalent DNA vaccines expressing HA antigens of H5N1 influenza viruses with an optimized leader sequence elicit cross-protective antibody responses.

Authors:  Shixia Wang; Anthony Hackett; Na Jia; Chunhua Zhang; Lu Zhang; Chris Parker; An Zhou; Jun Li; Wu-Chun Cao; Zuhu Huang; Yan Li; Shan Lu
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

10.  A serological survey of antibodies to H5, H7 and H9 avian influenza viruses amongst the duck-related workers in Beijing, China.

Authors:  Peng Yang; Chunna Ma; Weixian Shi; Shujuan Cui; Guilan Lu; Xiaomin Peng; Daitao Zhang; Yimeng Liu; Huijie Liang; Yi Zhang; Li Zhang; Holly Seale; Quanyi Wang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.